Are left ventricular ejection fraction phenotypes meaningful in acute heart failure?

Affiliations

¹ Centre d'Investigations Cliniques Plurithématique, CHRU de Nancy, INSERM 1433, INI-CRCT (Cardiovascular and Renal Clinical Trialists), Université de Lorraine, Nancy, France.
² CHRU de Nancy, Médecine Intensive et Réanimation Brabois, INSERM U1116, Université de Lorraine, Nancy, France.

Free article

Editorial

Guillaume Baudry et al. Eur J Heart Fail. 2023 Jun.

Free article

. 2023 Jun;25(6):829-831.

doi: 10.1002/ejhf.2889. Epub 2023 May 21.

¹ Centre d'Investigations Cliniques Plurithématique, CHRU de Nancy, INSERM 1433, INI-CRCT (Cardiovascular and Renal Clinical Trialists), Université de Lorraine, Nancy, France.
² CHRU de Nancy, Médecine Intensive et Réanimation Brabois, INSERM U1116, Université de Lorraine, Nancy, France.

No abstract available

Comment on

Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF.
Farmakis D, Tromp J, Marinaki S, Ouwerkerk W, Angermann CE, Bistola V, Dahlstrom U, Dickstein K, Ertl G, Ghadanfar M, Hassanein M, Obergfell A, Perrone SV, Polyzogopoulou E, Schweizer A, Boletis I, Cleland JGF, Collins SP, Lam CSP, Filippatos G. Farmakis D, et al. Eur J Heart Fail. 2023 Jun;25(6):818-828. doi: 10.1002/ejhf.2833. Epub 2023 Apr 12. Eur J Heart Fail. 2023. PMID: 36974770

1. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al.; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2022;24:4-131.
1. Farmakis D, Tromp J, Marinaki S, Ouwerkerk W, Angermann CE, Bistola V, Dahlstrom U, et al. Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF. Eur J Heart Fail. 2023;25:818-28.
1. Greene SJ, Fonarow GC, Butler J. REPORT-HF: The unique blend of global heart failure registry and longitudinal cohort study. Eur J Heart Fail. 2015;17:472-4.
1. Chioncel O, Mebazaa A, Harjola VP, Coats AJ, Piepoli MF, Crespo-Leiro MG, et al.; ESC Heart Failure Long-Term Registry Investigators. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: The ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017;19:1242-54.
1. Mebazaa A, Davison B, Chioncel O, Cohen-Solal A, Diaz R, Filippatos G, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): A multinational, open-label, randomised, trial. Lancet. 2022;400:1938-52.